ATE326970T1 - Verwendung von 4-(4-methylpiperazin-1-ylmethyl)-n 4-methyl-3-(4-pyridin-3-yl) pyrimidin-2-ylamino) phenyl benzamid zur behandlung von seminomen - Google Patents

Verwendung von 4-(4-methylpiperazin-1-ylmethyl)-n 4-methyl-3-(4-pyridin-3-yl) pyrimidin-2-ylamino) phenyl benzamid zur behandlung von seminomen

Info

Publication number
ATE326970T1
ATE326970T1 AT03742638T AT03742638T ATE326970T1 AT E326970 T1 ATE326970 T1 AT E326970T1 AT 03742638 T AT03742638 T AT 03742638T AT 03742638 T AT03742638 T AT 03742638T AT E326970 T1 ATE326970 T1 AT E326970T1
Authority
AT
Austria
Prior art keywords
seminomas
ylamino
ylmethyl
methyl
treatment
Prior art date
Application number
AT03742638T
Other languages
English (en)
Inventor
Michael C Heinrich
Christopher Corless
Kathleen Kemmer
Original Assignee
Us Gov Veterans Affairs
Univ Oregon Health & Science
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Gov Veterans Affairs, Univ Oregon Health & Science filed Critical Us Gov Veterans Affairs
Application granted granted Critical
Publication of ATE326970T1 publication Critical patent/ATE326970T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT03742638T 2002-02-22 2003-02-17 Verwendung von 4-(4-methylpiperazin-1-ylmethyl)-n 4-methyl-3-(4-pyridin-3-yl) pyrimidin-2-ylamino) phenyl benzamid zur behandlung von seminomen ATE326970T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US35904902P 2002-02-22 2002-02-22

Publications (1)

Publication Number Publication Date
ATE326970T1 true ATE326970T1 (de) 2006-06-15

Family

ID=27757766

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03742638T ATE326970T1 (de) 2002-02-22 2003-02-17 Verwendung von 4-(4-methylpiperazin-1-ylmethyl)-n 4-methyl-3-(4-pyridin-3-yl) pyrimidin-2-ylamino) phenyl benzamid zur behandlung von seminomen

Country Status (7)

Country Link
US (1) US20050153975A1 (de)
EP (1) EP1487452B1 (de)
JP (1) JP2005523282A (de)
AT (1) ATE326970T1 (de)
AU (1) AU2003209521A1 (de)
DE (1) DE60305460D1 (de)
WO (1) WO2003070248A1 (de)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW225528B (de) * 1992-04-03 1994-06-21 Ciba Geigy Ag
CO4940418A1 (es) * 1997-07-18 2000-07-24 Novartis Ag Modificacion de cristal de un derivado de n-fenil-2- pirimidinamina, procesos para su fabricacion y su uso
EE05107B1 (et) * 1999-10-19 2008-12-15 Merck & Co., Inc. Türosiinkinaasi pärssiv ühend, seda sisaldav farmatseutiline kompositsioon ning ühendi kasutamine
MY128450A (en) * 2000-05-24 2007-02-28 Upjohn Co 1-(pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives
US20020077301A1 (en) * 2000-10-05 2002-06-20 Whitehead Institute For Biomedical Research Effects of combined administration of farnesyl transferase inhibitors and signal transduction inhibitors

Also Published As

Publication number Publication date
JP2005523282A (ja) 2005-08-04
EP1487452A1 (de) 2004-12-22
DE60305460D1 (de) 2006-06-29
WO2003070248A1 (en) 2003-08-28
EP1487452B1 (de) 2006-05-24
AU2003209521A1 (en) 2003-09-09
US20050153975A1 (en) 2005-07-14

Similar Documents

Publication Publication Date Title
DE60118430D1 (de) Behandlung gastrointestinaler stroma-tumoren
HK1028599A1 (en) Crystal modification of a n-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use
TWI347186B (en) Salt forms of 4-(4-methylpiperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide
IL164678A (en) High-drug tablet containing 4– (4-methylpiprazine – 1-ylamethyl) -n - [(4-methyl-3– (4-pyridin-3-il) pyrimidine-2-ylamino) phenyl] -benzamide or compatible salt Its pharmaceutical and process for its preparation
ATE399555T1 (de) Behandlung der rheumatoiden arthritis mit imitanib
BR0316126A (pt) Combinação de compostos para o tratamento de leucemia linfocìtica crÈnica
IS2712B (is) Notkun týrósínkínasatálma til að meðhöndla sykursýki
ATE326970T1 (de) Verwendung von 4-(4-methylpiperazin-1-ylmethyl)-n 4-methyl-3-(4-pyridin-3-yl) pyrimidin-2-ylamino) phenyl benzamid zur behandlung von seminomen
BR0312242A (pt) 4-(4-metilpiperazin-1-ilmetil)-n-[4-metil-3-(4-piridin-3-il) pirimidin-2-ilamino)fenil]-benzamida para o tratamento da fibrose pulmonar
WO2004026930A3 (en) The method for reducing inflammation using sti-571 or its salt
ECSP982588A (es) Modificacion de cristal de un derivado de n-fenil -2-pirimidinamina procesos para su fabricacion y su uso

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties